The discussion about federal regulation for the cannabis industry is complex. The Council for Federal Cannabis Regulation wants to ensure that federal regulations are informed by and grounded in science, best business practices, sound public policy, and social justice principles. Sheri Orlowitz, founder and chairman of the board of the Council for Federal Cannabis Regulation, joins Perkins Coie partner Barak Cohen to discuss how additional regulatory oversight can benefit the cannabis industry. Sheri brings more than 30 years of experience as an entrepreneur, venture capitalist, turnaround expert, board director, corporate leader, attorney, and former federal prosecutor. Among other things, Barak and Sheri discuss the ongoing debate as to whether the U.S. Food and Drug Administration (FDA) or the Alcohol and Tobacco Tax and Trade Bureau ought to have primary oversight over cannabis and the potential benefits that could be available as a result of federal regulation.